Physician profile
Franklin J Lin
NPI 1679648927
$69,013.98
in general payments reported to CMS, 2019-2025
30 companies · $1,242 in 2025
The $1,242 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $15K · 2021: $16K · 2022: $16K · 2023: $233 · 2024: $719 · 2025: $1,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,193.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $36,153.03 | 2019-2025 | Altera, Vyrsa V1, Sable |
| Mirus, LLC | $28,271.00 | 2019-2022 | |
| Spineology INC. | $1,000.00 | 2020 | |
| Medtronic, INC. | $789.64 | 2021-2025 | Intellis Adaptivestim, O-Arm |
| Medtronic USA, INC. | $411.83 | 2019-2020 | |
| Nevro Corp. | $394.60 | 2022-2024 | Senza |
| Boston Scientific Corporation | $268.18 | 2020-2022 | |
| Depuy Synthes Sales INC. | $253.27 | 2019-2025 | Symphony, Teligen |
| Augmedics INC. | $252.18 | 2024 | Xvision |
| Intrinsic Therapeutics | $246.26 | 2025 | Barricaid Acd (Annular Closure Device) |
| Ucb, INC. | $177.77 | 2019-2020 | |
| Xtant Medical INC | $126.07 | 2025 | |
| Portola Pharmaceuticals, LLC | $122.27 | 2019 | |
| Abbott Laboratories | $85.86 | 2020 | |
| Stryker Corporation | $71.60 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $53.21 | 2022 | |
| Titan Spine, LLC | $45.18 | 2019 | |
| Avanos Medical | $36.52 | 2019 | |
| Natus Medical Incorporated | $30.12 | 2019 | |
| Chiesi USA, INC. | $29.59 | 2019 | |
| Spine Wave, INC. | $29.16 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $27.58 | 2025 | |
| Surgalign Spine Technologies, INC. | $21.70 | 2019 | |
| Solventum Corporation | $20.10 | 2025 | Prevena |
| Alphatec Spine, INC | $19.65 | 2022 | |
| Stimwave Technologies Incorporated | $18.54 | 2020 | |
| Si-Bone, INC. | $16.85 | 2019 | |
| Nuvasive, INC. | $15.68 | 2019 | |
| Misonix INC | $15.46 | 2019 | |
| Integra Lifesciences Corporation | $11.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Franklin Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.